Hedvig Hricak

Q: What Schools Are Affiliated With Hedvig Hricak

Hedvig Hricak is affiliated with the following schools: Weill Cornell Medicine, Queens University , Cornell University, University of New Mexico, University of California, San Francisco, University of Zagreb, Massachusetts General Hospital, Duke University, Karolinska Institute, Medical University of Graz, Brown University

Hedvig Hricak's AcademicInfluence.com Rankings

Hedvig Hricak

Medical

#231

World Rank

#347

Historical Rank

#109

USA Rank

Radiology

World Rank

#12

Historical Rank

USA Rank

medical Degrees

Download Badge

Medical

Why Is Hedvig Hricak Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Hedvig Hricak was born in 1946, in Zagreb, SR Croatia, SFR Yugoslavia and earned her MD degree from the School of Medicine, University of Zagreb in 1970. She was Chairman of the Department of Radiology, Memorial Sloan-Kettering Cancer Center from November 1999 to January 2023. She is professor of radiology at the Weill Medical College of Cornell University.

(See a Problem?)

Hedvig Hricak's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Radiomics: Images Are More than Pictures, They Are Data (2015) (4453)
Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. (1996) (623)
Imaging prostate cancer: a multidisciplinary perspective. (2007) (602)
Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study. (1999) (584)
Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy. (2005) (411)
Radiologic staging in patients with endometrial cancer: a meta-analysis. (1999) (405)
Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness. (2011) (401)
Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. (2006) (394)
Improving communication of diagnostic radiology findings through structured reporting. (2011) (385)
Vasculogenic impotence evaluated by high-resolution ultrasonography and pulsed Doppler spectrum analysis. (1985) (384)
Invasive cervical carcinoma: comparison of MR imaging and surgical findings. (1988) (366)
Cervical Carcinoma: Computed Tomography and Magnetic Resonance Imaging for Preoperative Staging (1995) (364)
Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. (1999) (351)
Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal--pelvic phased-array coils. (1994) (337)
Radiological evaluation of lymph node metastases in patients with cervical cancer. A meta-analysis. (1997) (326)
Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities. (2007) (325)
Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimensional conformal radiotherapy. (1996) (323)
Haralick texture analysis of prostate MRI: utility for differentiating non-cancerous prostate from prostate cancer and differentiating prostate cancers with different Gleason scores (2015) (322)
Peritoneal metastases: detection with spiral CT in patients with ovarian cancer. (2002) (308)
Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference (2016) (305)
Managing radiation use in medical imaging: a multifaceted challenge. (2011) (303)
Automatic classification of prostate cancer Gleason scores from multiparametric magnetic resonance images (2015) (298)
Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. (1995) (292)
Complex adnexal masses: detection and characterization with MR imaging--multivariate analysis. (2000) (282)
Solid renal cortical tumors: differentiation with CT. (2007) (279)
Detection of extracapsular extension of prostate carcinoma with endorectal and phased-array coil MR imaging: multivariate feature analysis. (1997) (277)
Magnetic resonance imaging with respiratory gating: techniques and advantages. (1984) (272)
Indeterminate ovarian mass at US: incremental value of second imaging test for characterization--meta-analysis and Bayesian analysis. (2005) (270)
Advances in magnetic resonance imaging: how they are changing the management of prostate cancer. (2011) (270)
Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence. (2007) (269)
Early invasive cervical cancer: tumor delineation by magnetic resonance imaging, computed tomography, and clinical examination, verified by pathologic results, in the ACRIN 6651/GOG 183 Intergroup Study. (2006) (264)
Prostate cancer aggressiveness: assessment with whole-lesion histogram analysis of the apparent diffusion coefficient. (2014) (261)
Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms. (2006) (248)
Prostatic carcinoma: staging by clinical assessment, CT, and MR imaging. (1987) (236)
Müllerian duct anomalies: MR imaging evaluation. (1990) (231)
Magnetic resonance imaging for predicting prostate biopsy findings in patients considered for active surveillance of clinically low risk prostate cancer. (2012) (225)
Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy. (1995) (225)
Radiogenomics of clear cell renal cell carcinoma: associations between CT imaging features and mutations. (2013) (221)
Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findings. (2008) (218)
Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging. (2002) (215)
Uterine leiomyomas: correlation of MR, histopathologic findings, and symptoms. (1986) (215)
Renal masses: characterization with diffusion-weighted MR imaging--a preliminary experience. (2008) (212)
Prostate cancer: correlation of MR imaging and MR spectroscopy with pathologic findings after radiation therapy-initial experience. (2005) (210)
Radiation exposure from medical imaging: time to regulate? (2010) (209)
Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183. (2005) (208)
Urinary continence after radical retropubic prostatectomy: relationship with membranous urethral length on preoperative endorectal magnetic resonance imaging. (2002) (208)
Bone marrow imaging: magnetic resonance studies related to age and sex. (1985) (207)
Prostate cancer: incremental value of endorectal MR imaging findings for prediction of extracapsular extension. (2004) (207)
Magnetic resonance imaging of the female pelvis: initial experience. (1983) (206)
Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer. (2005) (204)
Bladder tumor staging: comparison of contrast-enhanced CT, T1- and T2-weighted MR imaging, dynamic gadolinium-enhanced imaging, and late gadolinium-enhanced imaging. (1994) (199)
Ovarian cancer: staging with CT and MR imaging. (1995) (197)
Magnetic resonance imaging of the lymph nodes: comparison with CT. (1984) (197)
Recovery of urinary continence after radical prostatectomy: association with urethral length and urethral fibrosis measured by preoperative and postoperative endorectal magnetic resonance imaging. (2009) (196)
US characterization of ovarian masses: a meta-analysis. (2000) (196)
Lipomatous tumors and tumors with fatty component: MR imaging potential and comparison of MR and CT results. (1985) (196)
Prediction of deep myometrial invasion in patients with endometrial cancer: clinical utility of contrast-enhanced MR imaging-a meta-analysis and Bayesian analysis. (2000) (194)
Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume. (2009) (193)
Endometrial carcinoma staging by MR imaging. (1987) (191)
Nuclear magnetic resonance imaging of the cardiovascular system: normal and pathologic findings. (1983) (189)
2-[18F]Fluoro-2-Deoxyglucose Positron Emission Tomography for the Detection of Disease in Patients with Prostate-Specific Antigen Relapse after Radical Prostatectomy (2005) (187)
Management of the fetus with congenital hydronephrosis. (1982) (184)
Association of Renal Agenesis and Mullerian Duct Anomalies (2000) (184)
MR imaging evaluation of endometrial carcinoma: results of an NCI cooperative study. (1991) (183)
The prostate: MR imaging and spectroscopy. Present and future. (2000) (182)
Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging--initial results. (2003) (178)
The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis (2007) (177)
Prostate cancer: detection of extracapsular extension by genitourinary and general body radiologists at MR imaging. (2004) (177)
Pretreatment evaluation of prostate cancer: role of MR imaging and 1H MR spectroscopy. (2004) (177)
A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer. (2014) (176)
Functional evaluation of penile veins by cavernosography in papaverine-induced erection. (1986) (175)
Renal parenchymal disease: sonographic-histologic correlation. (1982) (174)
CT findings of chemotherapy-induced toxicity: what radiologists need to know about the clinical and radiologic manifestations of chemotherapy toxicity. (2011) (171)
Adenomyosis and leiomyoma: differential diagnosis with MR imaging. (1987) (167)
Localizing prostate cancer in the presence of postbiopsy changes on MR images: role of proton MR spectroscopic imaging. (1998) (166)
Pattern of prostate-specific antigen (PSA) failure dictates the probability of a positive bone scan in patients with an increasing PSA after radical prostatectomy. (2005) (166)
MR imaging of the prostate gland: normal anatomy. (1987) (165)
Invasive cervical carcinoma: role of MR imaging in pretreatment work-up--cost minimization and diagnostic efficacy analysis. (1996) (162)
Ovarian lesions: detection and characterization with gadolinium-enhanced MR imaging at 1.5 T. (1991) (162)
Early invasive cervical cancer: CT and MR imaging in preoperative evaluation - ACRIN/GOG comparative study of diagnostic performance and interobserver variability. (2007) (160)
Carcinoma of the uterus: use of gadopentetate dimeglumine in MR imaging. (1991) (159)
Molecular imaging for personalized cancer care (2012) (159)
Prostate cancer: metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging. (1996) (157)
Assessment of biologic aggressiveness of prostate cancer: correlation of MR signal intensity with Gleason grade after radical prostatectomy. (2008) (157)
Endorectal MR imaging in the evaluation of seminal vesicle invasion: diagnostic accuracy and multivariate feature analysis. (2006) (153)
Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer. (2005) (153)
CT and MRI of pelvic varices in women. (1999) (150)
Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging. (2004) (148)
Prediction of seminal vesicle invasion in prostate cancer: incremental value of adding endorectal MR imaging to the Kattan nomogram. (2007) (144)
Chronic prostatitis: MR imaging and 1H MR spectroscopic imaging findings--initial observations. (2004) (144)
Diagnosis of urethral diverticula in women: value of MR imaging. (1993) (144)
Normal and hypoplastic fetal lungs: volumetric assessment with prenatal single-shot rapid acquisition with relaxation enhancement MR imaging. (2000) (143)
MR imaging and MR spectroscopic imaging in the pre-treatment evaluation of prostate cancer. (2005) (142)
The role of preoperative endorectal magnetic resonance imaging in the decision regarding whether to preserve or resect neurovascular bundles during radical retropubic prostatectomy (2004) (137)
Nuclear magnetic resonance imaging of the kidney. (1983) (136)
Characterization of lymphadenopathy by magnetic resonance relaxation times: preliminary results. (1985) (135)
Aortic dissection: magnetic resonance imaging. (1985) (135)
Magnetic resonance imaging of the body (1987) (134)
Endorectal MR imaging before salvage prostatectomy: tumor localization and staging. (2006) (133)
Radiology in invasive cervical cancer. (1996) (131)
Complex fetal disorders: effect of MR imaging on management--preliminary clinical experience. (1999) (130)
Evaluating localized prostate cancer and identifying candidates for focal therapy. (2008) (129)
Anatomy and pathology of the male pelvis by magnetic resonance imaging. (1983) (128)
Functional magnetic resonance imaging in prostate cancer. (2009) (125)
MR imaging of treated prostate cancer. (2012) (125)
Localized prostate cancer: effect of hormone deprivation therapy measured by using combined three-dimensional 1H MR spectroscopy and MR imaging: clinicopathologic case-controlled study. (2001) (124)
Time‐dependent effects of hormone‐deprivation therapy on prostate metabolism as detected by combined magnetic resonance imaging and 3D magnetic resonance spectroscopic imaging (2001) (123)
Dynamic contrast-enhanced magnetic resonance imaging and pharmacokinetic models in prostate cancer (2011) (122)
Magnetic resonance imaging in the diagnosis and staging of renal and perirenal neoplasms. (1985) (121)
Pelvic endometriosis: MR imaging. (1989) (121)
Transatlantic Consensus Group on active surveillance and focal therapy for prostate cancer (2012) (120)
Nuclear magnetic resonance imaging of atherosclerotic disease. (1983) (118)
Clinical application of BASING and spectral/spatial water and lipid suppression pulses for prostate cancer staging and localization by in vivo 3D 1H magnetic resonance spectroscopic imaging (2000) (117)
Scrotal ultrasound in the infertile man: detection of subclinical unilateral and bilateral varicoceles. (1986) (117)
The potential impact of nuclear magnetic resonance imaging on cardiovascular diagnosis. (1983) (117)
Brachytherapy for prostate cancer: endorectal MR imaging of local treatment-related changes. (2001) (116)
Multiparametric prostate MR imaging with T2-weighted, diffusion-weighted, and dynamic contrast-enhanced sequences: are all pulse sequences necessary to detect locally recurrent prostate cancer after radiation therapy? (2013) (113)
Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer (2012) (113)
Detection and staging of renal neoplasms: a reassessment of MR imaging. (1988) (113)
Background, current role, and potential applications of radiogenomics (2018) (113)
18F-FDG PET Scanning Correlates with Tissue Markers of Poor Prognosis and Predicts Mortality for Patients After Liver Resection for Colorectal Metastases (2007) (111)
Imaging prostate cancer. (2000) (111)
Sonographic determination of renal volume. (1983) (110)
Uterine MR imaging: effects of hormonal stimulation. (1986) (109)
Malignant versus nonmalignant retroperitoneal fibrosis: differentiation with MR imaging. (1989) (109)
Obstetrical magnetic resonance imaging: maternal anatomy. (1985) (108)
Postirradiation changes in the pelvis: assessment with MR imaging. (1990) (108)
Multidisciplinary Recommendations Regarding Post-Vaccine Adenopathy and Radiologic Imaging: Radiology Scientific Expert Panel (2021) (107)
Prostate cancer imaging (2008) (105)
Nuclear magnetic resonance imaging of the kidney: renal masses. (1983) (105)
Chronic renal failure: A significant risk factor in the development of acquired renal cysts and renal cell carcinoma. Case reports and review of the literature (1986) (104)
Sonography of testicular trauma. (1983) (103)
Differentiation of Uterine Leiomyosarcoma from Atypical Leiomyoma: Diagnostic Accuracy of Qualitative MR Imaging Features and Feasibility of Texture Analysis (2017) (103)
Radiologic anatomy of the prostate gland: a clinical approach. (2000) (102)
Urinary bladder MR imaging. Part II. Neoplasm. (1985) (102)
Fetal renal dysplasia: sonographic evaluation. (1984) (102)
Pelvic endometriosis: MR imaging spectrum with laparoscopic correlation and diagnostic pitfalls. (1997) (101)
MRI-Safe Robot for Endorectal Prostate Biopsy (2014) (100)
Transition zone prostate cancer: incremental value of diffusion-weighted endorectal MR imaging in tumor detection and assessment of aggressiveness. (2013) (100)
Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer. (2014) (100)
Normal central zone of the prostate and central zone involvement by prostate cancer: clinical and MR imaging implications. (2012) (100)
Pelvimetry by magnetic resonance imaging. (1985) (98)
Teratomas versus cystic hemorrhagic adnexal lesions: differentiation with proton-selective fat-saturation MR imaging. (1993) (97)
Combined endorectal and phased-array MRI in the prediction of pelvic lymph node metastasis in prostate cancer. (2006) (97)
Radiation-induced decrease in nitric oxide synthase--containing nerves in the rat penis. (1995) (97)
Detection of prostate cancer with MR spectroscopic imaging: an expanded paradigm incorporating polyamines. (2007) (96)
Female urethra: MR imaging. (1991) (95)
Subclinical varicocele: the effectiveness of varicocelectomy. (1991) (94)
Irradiation of the cervix uteri: value of unenhanced and contrast-enhanced MR imaging. (1993) (91)
Carcinoma of the cervix: predictive value of clinical and magnetic resonance (MR) imaging assessment of prognostic factors. (1993) (91)
Abdominal venous system: assessment using MR. (1985) (91)
Original Articles: Prostate Cancer (1995) (91)
Imaging approaches to optimize molecular therapies (2016) (90)
Combined gadolinium-enhanced and fat-saturation MR imaging of renal masses. (1991) (89)
Obstructive nephropathy: evaluation with dynamic Gd-DTPA-enhanced MR imaging. (1990) (88)
Use of an agonistic analog of gonadotropin-releasing hormone (nafarelin) to treat leiomyomas: assessment by magnetic resonance imaging. (1988) (87)
MR imaging in the evaluation of benign uterine masses: value of gadopentetate dimeglumine-enhanced T1-weighted images. (1992) (87)
Incremental value of diffusion weighted and dynamic contrast enhanced MRI in the detection of locally recurrent prostate cancer after radiation treatment: preliminary results (2011) (86)
Performance characteristics of MR imaging in the evaluation of clinically low-risk prostate cancer: a prospective study. (2012) (86)
Bone metastases in castration-resistant prostate cancer: associations between morphologic CT patterns, glycolytic activity, and androgen receptor expression on PET and overall survival. (2014) (85)
Magnetic resonance imaging of aortic disease: preliminary results. (1984) (84)
Interactive dedicated training curriculum improves accuracy in the interpretation of MR imaging of prostate cancer (2010) (84)
Normal penile anatomy and abnormal penile conditions: evaluation with MR imaging. (1988) (84)
Sonographic findings in perforation of the gallbladder. (1982) (83)
Intra- and interobserver variability in CT measurements in oncology. (2013) (82)
MRI of the female pelvis: a review. (1986) (82)
Monitoring the Efficacy of Adoptively Transferred Prostate Cancer–Targeted Human T Lymphocytes with PET and Bioluminescence Imaging (2008) (82)
A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithelial ovarian cancer. (2017) (82)
Imaging the testis: comparison between MR imaging and US. (1988) (81)
Diagnostic Performance of Vesical Imaging Reporting and Data System for the Prediction of Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis. (2020) (81)
MR imaging of traumatic posterior urethral injury. (1993) (81)
Radiotheranostics: a roadmap for future development. (2020) (79)
Ovarian cancer recurrence: value of MR imaging. (1995) (79)
MR imaging of the prostate in clinical practice (2008) (78)
Stage IB1 cervical cancer: role of preoperative MR imaging in selection of patients for fertility-sparing radical trachelectomy. (2013) (78)
Escherichia coli Nissle 1917 Facilitates Tumor Detection by Positron Emission Tomography and Optical Imaging (2008) (77)
Prostate cancer localization with endorectal MR imaging and MR spectroscopic imaging: effect of clinical data on reader accuracy. (2004) (76)
Value of the hemorrhage exclusion sign on T1-weighted prostate MR images for the detection of prostate cancer. (2012) (76)
Vagina: evaluation with MR imaging. Part I. Normal anatomy and congenital anomalies. (1988) (75)
Hormonal ablation of prostatic cancer: effects on prostate morphology, tumor detection, and staging by endorectal coil MR imaging. (1996) (74)
Magnetic resonance imaging in the evaluation of abscesses. (1985) (74)
MAGNETIC RESONANCE TOMOGRAPHY (2008) (73)
Undescended testis: value of MR imaging. (1987) (73)
Hyperpolarized MRI of Human Prostate Cancer Reveals Increased Lactate with Tumor Grade Driven by Monocarboxylate Transporter 1. (2020) (73)
Evaluation of prostate size: A comparison of ultrasound and magnetic resonance imaging (1988) (73)
Primary amenorrhea: evaluation with MR imaging. (1997) (72)
Utilization of diagnostic studies in the pretreatment evaluation of invasive cervical cancer in the United States: results of intergroup protocol ACRIN 6651/GOG 183. (2005) (71)
Advances in imaging in the postoperative patient with a rising prostate-specific antigen level. (2003) (71)
Posttraumatic impotence: magnetic resonance imaging and duplex ultrasound in diagnosis and management. (1993) (71)
Prospective evaluation of MRI, ¹¹C-acetate PET/CT and contrast-enhanced CT for staging of bladder cancer. (2012) (70)
Prostate MRI: Evaluating Tumor Volume and Apparent Diffusion Coefficient as Surrogate Biomarkers for Predicting Tumor Gleason Score (2014) (70)
Neonatal kidneys: sonographic anatomic correlation. (1982) (70)
A novel representation of inter-site tumour heterogeneity from pre-treatment computed tomography textures classifies ovarian cancers by clinical outcome (2017) (70)
MR imaging of renal cortical tumours: qualitative and quantitative chemical shift imaging parameters (2013) (69)
Magnetic resonance imaging of developmental venous anomalies. (1985) (69)
Fat-saturation MR imaging of the upper abdomen. (1990) (69)
Pelvic fistulas: appearances on MR images (1997) (69)
Prostate carcinoma: MR imaging findings after cryosurgery. (1996) (68)
Body MRI: alleviation of claustrophobia by prone positioning. (1984) (66)
Recurrent ovarian cancer: use of contrast-enhanced CT and PET/CT to accurately localize tumor recurrence and to predict patients' survival. (2010) (65)
Magnetic resonance imaging of fetal anomalies in utero: early experience. (1985) (65)
Magnetic resonance imaging of traumatic posterior urethral defects and pelvic crush injuries. (1992) (65)
Imaging of peritoneal and mesenteric disease: key concepts for the clinical radiologist. (1999) (65)
Recent advances in imaging studies for staging of penile and urethral carcinoma. (1992) (64)
Comparison of magnetic resonance imaging and ultrasonography in the evaluation of abdominal aortic aneurysms. (1985) (64)
Sonography of the scrotum. (1983) (63)
Medical imaging and nuclear medicine: a Lancet Oncology Commission. (2021) (62)
MR imaging evaluation of benign mesenchymal tumors of the urinary bladder. (1997) (62)
Clinical stage T1c prostate cancer: evaluation with endorectal MR imaging and MR spectroscopic imaging. (2009) (62)
The accuracy of magnetic resonance imaging in staging of vulvar cancer: a retrospective multi-centre study. (2010) (61)
Image artifacts on prostate diffusion-weighted magnetic resonance imaging: trade-offs at 1.5 Tesla and 3.0 Tesla. (2013) (61)
Patient perspectives and preferences for communication of medical imaging risks in a cancer care setting. (2015) (61)
Renal allografts: evaluation by MR imaging. (1986) (61)
Combined PET/MR: The Real Work Has Just Started. Summary Report of the Third International Workshop on PET/MR Imaging; February 17–21, 2014, Tübingen, Germany (2015) (61)
Prospective study of the correlation between postoperative computed tomography scan and primary surgeon assessment in patients with advanced ovarian, tubal, and peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residual disease 1 cm or less. (2007) (60)
Diagnosis of Extracapsular Extension of Prostate Cancer on Prostate MRI: Impact of Second-Opinion Readings by Subspecialized Genitourinary Oncologic Radiologists. (2015) (60)
Preoperative staging of cervical carcinoma: phased array coil fast spin-echo versus body coil spin-echo T2-weighted MR imaging. (1998) (59)
Gestational trophoblastic neoplasm of the uterus: MR assessment. (1986) (59)
Complex and simple renal cysts: comparative evaluation with MR imaging. (1987) (58)
Radiation-induced uterine changes: MR imaging. (1989) (58)
Distribution of renal tumor growth rates determined by using serial volumetric CT measurements. (2009) (57)
Evaluation of arteriogenic impotence with intracorporeal injection of papaverine and the duplex ultrasound scanner. (1985) (57)
The Effect of Magnetic Resonance Imagers on Implanted Neurostimulators (1992) (56)
The role of MR imaging in determining surgical eligibility for pelvic exenteration. (1993) (56)
The incremental value of contrast-enhanced MRI in the detection of biopsy-proven local recurrence of prostate cancer after radical prostatectomy: effect of reader experience. (2012) (55)
Use of DWI in the Differentiation of Renal Cortical Tumors. (2016) (55)
Adnexal structures: MR imaging. (1986) (55)
MR imaging in the diagnosis of pancreatic disease. (1987) (55)
Nuclear magnetic resonance imaging of the adrenal gland: a preliminary report. (1983) (54)
Imaging in the Age of Precision Medicine: Summary of the Proceedings of the 10th Biannual Symposium of the International Society for Strategic Studies in Radiology. (2016) (54)
New treatments for localized prostate cancer. (2008) (54)
Vagina: evaluation with MR imaging. Part II. Neoplasms. (1988) (54)
Intraoperative conformal optimization for transperineal prostate implantation using magnetic resonance spectroscopic imaging. (2000) (53)
Acute post-transplantation renal failure: differential diagnosis by ultrasound. (1981) (53)
A New Pyrimidine-Specific Reporter Gene: A Mutated Human Deoxycytidine Kinase Suitable for PET During Treatment with Acycloguanosine-Based Cytotoxic Drugs (2010) (53)
Assessment of Prostate Cancer Aggressiveness by Use of the Combination of Quantitative DWI and Dynamic Contrast-Enhanced MRI. (2016) (53)
Molecular Imaging of Prostate Cancer. (2016) (53)
Semi‐automatic deformable registration of prostate MR images to pathological slices (2010) (52)
The ovary. Computed tomography and magnetic resonance imaging. (1993) (52)
Cryptorchidism: strategies in detection (1999) (52)
Varicoceles. Radiologic diagnosis and treatment. (1991) (50)
Early invasive cervical cancer: MRI and CT predictors of lymphatic metastases in the ACRIN 6651/GOG 183 intergroup study. (2009) (50)
Perihepatic metastases from ovarian cancer: sensitivity and specificity of CT for the detection of metastases with and those without liver parenchymal invasion. (2008) (49)
Global trends in hybrid imaging. (2010) (49)
Magnetic resonance imaging of renal carcinoma with extension into the vena cava: staging accuracy and recent advances. (1991) (49)
MR imaging of the female pelvis. (1996) (49)
Advances in oncologic imaging (2012) (49)
Obstetrical magnetic resonance imaging: fetal anatomy. (1985) (49)
MR imaging of fat. (1986) (49)
Prostate Cancer: assessing the effects of androgen-deprivation therapy using quantitative diffusion-weighted and dynamic contrast-enhanced MRI (2015) (48)
Imaging for recurrent prostate cancer. (2000) (48)
Mixed müllerian sarcoma of the uterus: MR imaging findings. (1989) (48)
Role of MRI in prostate cancer detection (2014) (48)
The impact of FDG-PET/CT in the management of patients with vulvar and vaginal cancer. (2016) (47)
Imaging a Genetically Engineered Oncolytic Vaccinia Virus (GLV-1h99) Using a Human Norepinephrine Transporter Reporter Gene (2009) (47)
MR imaging of the dilated biliary tract. (1986) (47)
Retained seminal vesicles after radical prostatectomy: frequency, MRI characteristics, and clinical relevance. (2006) (47)
MRI of the prostate: Clinical relevance and emerging applications (2011) (46)
MR imaging of the seminal vesicles. (1991) (46)
Second-Opinion Interpretations of Gynecologic Oncologic MRI Examinations by Sub-Specialized Radiologists Influence Patient Care (2015) (46)
Pleural effusion detected at CT prior to primary cytoreduction for stage III or IV ovarian carcinoma: effect on survival. (2011) (46)
Work in progress: nuclear magnetic resonance imaging of the gallbladder. (1983) (45)
Experimental study of the sonographic diagnosis of testicular torsion. (1983) (45)
Women in radiology: gender diversity is not a metric—it is a tool for excellence (2019) (44)
Accelerating anticancer drug development — opportunities and trade-offs (2018) (44)
Hepatic vascular anatomy on magnetic resonance imaging. (1985) (44)
Cholangiocarcinoma: imaging by MR. (1986) (44)
MR in renal disease: Importance of cortical–medullary distinction (1987) (44)
Oncologic imaging: a guiding hand of personalized cancer care. (2011) (44)
How Sure Are You, Doctor? A Standardized Lexicon to Describe the Radiologist's Level of Certainty. (2016) (44)
The value of MR imaging when the site of uterine cancer origin is uncertain. (2011) (43)
Pictorial essay: Prenatal MR imaging of congenital diaphragmatic hernia (2000) (43)
Volume-based quantitative FDG PET/CT metrics and their association with optimal debulking and progression-free survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery (2015) (43)
Prognostic Significance of Supradiaphragmatic Lymphadenopathy Identified on Preoperative Computed Tomography Scan in Patients Undergoing Primary Cytoreduction for Advanced Epithelial Ovarian Cancer (2010) (43)
Association between morphologic CT imaging traits and prognostically relevant gene signatures in women with high-grade serous ovarian cancer: a hypothesis-generating study. (2015) (43)
MRI-guided Radiation Therapy: An Emerging Paradigm in Adaptive Radiation Oncology. (2020) (43)
Intrauterine contraceptive devices: MR imaging. (1987) (42)
Role of CT in the management of recurrent ovarian cancer. (2004) (42)
Posttransplant renal rejection: comparison of quantitative scintigraphy, US, and MR imaging. (1987) (42)
Complex posttransplantation abnormalities of renal allografts: evaluation with MR imaging. (1999) (42)
MR Imaging of Intramuscular Hemorrhage (1985) (42)
Blood loss during radical retropubic prostatectomy: relationship to morphologic features on preoperative endorectal magnetic resonance imaging. (2002) (41)
Focal treatment or observation of prostate cancer: pretreatment accuracy of transrectal ultrasound biopsy and T2-weighted MRI. (2010) (41)
Gynecologic masses: value of magnetic resonance imaging. (1985) (41)
Relative Intensity of Abdominal Organs in MR Images (1985) (41)
Reducing the influence of b‐value selection on diffusion‐weighted imaging of the prostate: Evaluation of a revised monoexponential model within a clinical setting (2012) (41)
Magnetic resonance imaging and spectroscopy of the periarticular inflammatory soft-tissue changes in experimental arthritis of the rat. (1985) (40)
Predicting post-external beam radiation therapy PSA relapse of prostate cancer using pretreatment MRI. (2010) (40)
CT and MRI of ovarian cancer (2004) (40)
Imaging of Lymph Node Micrometastases Using an Oncolytic Herpes Virus and [18F]FEAU PET (2009) (40)
Bladder cancer: can imaging change patient management? (2008) (39)
Müllerian duct cyst: diagnosis with MR imaging. (1988) (39)
Advances in imaging (1988) (39)
Value of a standardized lexicon for reporting levels of diagnostic certainty in prostate MRI. (2014) (39)
Magnetic resonance imaging in the prediction of biochemical recurrence of prostate cancer after radical prostatectomy (2009) (39)
Nuclear magnetic resonance imaging in retroperitoneal fibrosis. (1983) (39)
High-Grade Serous Ovarian Cancer: Associations between BRCA Mutation Status, CT Imaging Phenotypes, and Clinical Outcomes. (2017) (39)
Localizing sites of disease in patients with rising serum prostate-specific antigen up to 1ng/ml following prostatectomy: How much information can conventional imaging provide? (2016) (39)
Differentiation of Clear Cell Renal Cell Carcinoma From Other Renal Cortical Tumors by Use of a Quantitative Multiparametric MRI Approach. (2017) (38)
Imaging of transposed ovaries in patients with cervical carcinoma. (2005) (38)
Endorectal MRI of prostatic and periprostatic cystic lesions and their mimics. (2007) (38)
Prediction of Prostate Cancer Recurrence Using Magnetic Resonance Imaging and Molecular Profiles (2009) (38)
The value of 18F-FDG PET/CT in recurrent gynecologic malignancies prior to pelvic exenteration. (2013) (37)
Urinary bladder MR imaging. Part I. Normal and benign conditions. (1985) (37)
MR imaging using specialized coils. (1985) (36)
Imaging of ovarian cancer (1995) (36)
Imaging hypoxia in orthotopic rat liver tumors with iodine 124-labeled iodoazomycin galactopyranoside PET. (2008) (36)
Sonography of acute scrotal abnormalities. (1983) (36)
Pretreatment endorectal coil magnetic resonance imaging findings predict biochemical tumor control in prostate cancer patients treated with combination brachytherapy and external-beam radiotherapy. (2012) (35)
Incremental value of multiplanar cross-referencing for prostate cancer staging with endorectal MRI. (2007) (35)
Magnetic resonance imaging in the evaluation of congenital anomalies of the external genitalia. (2001) (35)
Prospective Study of the Radiolabeled GRPR Antagonist BAY86-7548 for Positron Emission Tomography/Computed Tomography Imaging of Newly Diagnosed Prostate Cancer. (2019) (35)
Magnetic resonance imaging of the female pelvis: Initial experience (1984) (35)
Multiphasic contrast‐enhanced MRI: Single‐slice versus volumetric quantification of tumor enhancement for the assessment of renal clear‐cell carcinoma fuhrman grade (2013) (35)
Diffusion-weighted MRI of the prostate at 3.0 T: comparison of endorectal coil (ERC) MRI and phased-array coil (PAC) MRI-The impact of SNR on ADC measurement. (2013) (34)
The role of ultrasound in the diagnosis of kidney allograft rejection. (1979) (34)
Measuring tumor response and shape change on CT: esophageal cancer as a paradigm. (2006) (34)
Assessment of renal viability by phosphorus-31 magnetic resonance spectroscopy. (1986) (34)
Intrauterine growth retardation: evaluation by magnetic resonance. Work in progress. (1985) (33)
Magnetic resonance imaging and magnetic resonance spectroscopic imaging of prostate cancer (2005) (32)
Association between CT-texture-derived tumor heterogeneity, outcomes, and BRCA mutation status in patients with high-grade serous ovarian cancer (2018) (32)
MR imaging of bladder neoplasms: Correlation with pathologic staging (1990) (32)
Sonographic findings in complicated peptic ulcer. (1981) (32)
MR image contrast and relaxation times of solid tumors in the chest, abdomen, and pelvis. (1985) (32)
Blueprint for imaging in biomedical research. (2007) (32)
Cancer of the uterus: the value of MRI pre- and post-irradiation. (1991) (32)
1H magnetic resonance spectroscopy of prostate cancer: biomarkers for tumor characterization. (2008) (32)
Combined Whole Body and Multiparametric Prostate Magnetic Resonance Imaging as a 1‐Step Approach to the Simultaneous Assessment of Local Recurrence and Metastatic Disease after Radical Prostatectomy (2017) (31)
Multiparametric 3T MRI for the prediction of pathological downgrading after radical prostatectomy in patients with biopsy-proven Gleason score 3 + 4 prostate cancer (2014) (31)
Correlation of MR imaging and MR spectroscopic imaging findings with Ki-67, phospho-Akt, and androgen receptor expression in prostate cancer. (2009) (31)
Estimating the impact of treatment and imaging modalities on 5-year net survival of 11 cancers in 200 countries: a simulation-based analysis. (2020) (31)
Magnetic resonance imaging of the normal and pathologic muscular system (1986) (31)
Anatomic segmentation improves prostate cancer detection with artificial neural networks analysis of 1H magnetic resonance spectroscopic imaging (2014) (30)
MRI of the Pelvis: A Text Atlas (1992) (30)
Global Challenges for Cancer Imaging (2017) (30)
Gallbladder bile: an experimental study in dogs using MR imaging and proton MR spectroscopy. (1985) (30)
Imaging in gynecologic malignancies (1993) (29)
Magnetic Resonance Imaging/Positron Emission Tomography Provides a Roadmap for Surgical Planning and Serves as a Predictive Biomarker in Patients With Recurrent Gynecological Cancers Undergoing Pelvic Exenteration (2013) (29)
The renal sinus during allograft rejection: sonographic and histopathologic findings. (1982) (29)
Preliminary assessment of magnetic resonance spectroscopic imaging in predicting treatment outcome in patients with prostate cancer at high risk for relapse. (2004) (29)
Contrast media for angiography: effect on renal function. (1986) (29)
Sonographic evaluation of experimental acute renal arterial occlusion in dogs. (1984) (29)
Peritoneal inclusion cysts: clinical characteristics and imaging features (2013) (29)
Tumor hypoxia imaging in orthotopic liver tumors and peritoneal metastasis: a comparative study featuring dynamic 18F-MISO and 124I-IAZG PET in the same study cohort (2007) (29)
Dynamic contrast-enhanced magnetic resonance imaging of prostate cancer: A review of current methods and applications (2017) (28)
MR imaging evaluation of renal cell carcinoma (1997) (28)
Magnetic resonance imaging in urology. (1984) (28)
Diagnostic Imaging: Gynecology (2007) (28)
Evaluation of acute post-transplant renal failure by ultrasound. (1979) (28)
Detection of extracapsular extension of prostate cancer: role of fat suppression endorectal MRI. (1999) (28)
MRI at the completion of chemoradiotherapy can accurately evaluate the extent of disease in women with advanced urethral carcinoma undergoing anterior pelvic exenteration. (2011) (28)
Renal allograft rejection: US evaluation. (1986) (27)
The role of MRI and MRSI in diagnosis, treatment selection, and post-treatment follow-up for prostate cancer. (2009) (27)
Comparison of Magnetic Resonance Imaging-stratified Clinical Pathways and Systematic Transrectal Ultrasound-guided Biopsy Pathway for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials. (2019) (27)
Renal Masses Detected on FDG PET/CT in Patients With Lymphoma: Imaging Features Differentiating Primary Renal Cell Carcinomas From Renal Lymphomatous Involvement. (2017) (27)
Cervical incompetence: preliminary evaluation with MR imaging. (1990) (26)
2016 New Horizons Lecture: Beyond Imaging-Radiology of Tomorrow. (2018) (26)
Infected aortoiliofemoral grafts: magnetic resonance imaging. (1985) (26)
Local detection of prostate cancer by positron emission tomography with 2-fluorodeoxyglucose: comparison of filtered back projection and iterative reconstruction with segmented attenuation correction. (2001) (26)
Imaging and management of atypical testicular masses. (1998) (26)
Imaging of hypoxia-driven gene expression in an orthotopic liver tumor model (2007) (25)
Validity of prostate‐specific antigen as a tumour marker in men with prostate cancer managed by watchful‐waiting: correlation with findings at serial endorectal magnetic resonance imaging and spectroscopic imaging (2007) (25)
The role and contribution of treatment and imaging modalities in global cervical cancer management: survival estimates from a simulation-based analysis. (2020) (25)
Ornithine Decarboxylase Is Sufficient for Prostate Tumorigenesis via Androgen Receptor Signaling. (2016) (25)
Nuclear magnetic resonance imaging of vasculature of abdominal viscera: normal and pathologic features. (1983) (25)
Assessment of clinical renal preservation by phosphorus-31 magnetic resonance spectroscopy. (1987) (25)
Anatomy and pathology of the male pelvis by magnetic resonance imaging (1984) (25)
Clear Cell Renal Cell Carcinoma: Associations Between CT Features and Patient Survival. (2016) (24)
Cholecystitis: detection with MR imaging. (1986) (24)
Cine gradient refocused echo (GRE) imaging of intravascular masses: differentiation between tumor and nontumor thrombus. (1992) (24)
Global costs, health benefits, and economic benefits of scaling up treatment and imaging modalities for survival of 11 cancers: a simulation-based analysis. (2021) (24)
Nuclear magnetic resonance imaging characteristics of gallstones in vitro. (1983) (24)
Diagnostic performance of conventional and advanced imaging modalities for assessing newly diagnosed cervical cancer: systematic review and meta-analysis (2020) (23)
Assessment of renal preservation by phosphorus-31 magnetic resonance spectroscopy: in vivo normothermic blood perfusion. (1986) (23)
MR imaging of the uterus: low-signal-intensity abnormalities of the endometrium and endometrial cavity. (1990) (23)
Abdominopelvic MR imaging in the nonobstetric evaluation of pregnant patients. (1996) (22)
MR imaging of the kidney. (1984) (22)
CT Features of Ovarian Tumors: Defining Key Differences Between Serous Borderline Tumors and Low-Grade Serous Carcinomas. (2018) (22)
Role of MRI in the valuation of ambiguous genitalia (2005) (22)
Role of Imaging in the Pretreatment Evaluation of Common Gynecological Cancers (2014) (22)
MRI findings of radiation-induced changes in the urethra and periurethral tissues after treatment for prostate cancer. (2013) (22)
MR Imaging of Body Fluid Collections (1986) (22)
Renal malignancies with normal excretory urograms. (1983) (22)
Molecular MR imaging in oncology. (2005) (22)
Pelvis imaging with MR: technique for improvement. (1986) (22)
Developments in nuclear magnetic resonance imaging and spectroscopy: application to radiation oncology. (2001) (21)
Primary Diagnosis of Abdominal Arteriovenous Fistula by MR Imaging (1984) (21)
Magnetic resonance imaging and its application in urology. (1984) (21)
Characterization of Adnexal Masses Using Feature Analysis at Contrast-Enhanced Helical Computed Tomography (2008) (21)
Role of preoperative MR imaging in the evaluation of patients with persistent or recurrent gynaecological malignancies before pelvic exenteration (2013) (21)
Comparison of prostate volume measured by endorectal coil MRI to prostate specimen volume and mass after radical prostatectomy. (2015) (21)
In vivo human testicular function assessed with P-31 MR spectroscopy. (1990) (20)
MR imaging of the prostate (2002) (20)
Sonographic manifestations of acute renal vein thrombosis: an experimental study. (1981) (19)
Extension of gastric lymphoma into the esophagus and duodenum. (1980) (19)
Renal cell carcinoma: role of MR imaging in the assessment of muscular venous branch invasion. (2013) (19)
Regarding the focal treatment of prostate cancer: inference of the Gleason grade from magnetic resonance spectroscopic imaging. (2009) (19)
Early postoperative CT as a prognostic biomarker in patients with advanced ovarian, tubal, and primary peritoneal cancer deemed optimally debulked at primary cytoreductive surgery. (2012) (19)
Prostate cancer bone metastases on staging prostate MRI: prevalence and clinical features associated with their diagnosis (2016) (19)
A New Acycloguanosine-Specific Supermutant of Herpes Simplex Virus Type 1 Thymidine Kinase Suitable for PET Imaging and Suicide Gene Therapy for Potential Use in Patients Treated with Pyrimidine-Based Cytotoxic Drugs (2008) (19)
MRI‐safe robot for targeted transrectal prostate biopsy: animal experiments (2014) (19)
Radiologic imaging modalities, including magnetic resonance, for evaluating lymph nodes. (1986) (19)
Magnetic resonance imaging in the diagnosis of acute renal allograft rejection and its differentiation from acute tubular necrosis. Experimental study in the dog. (1985) (19)
Imaging of prostate cancer. (2002) (19)
Complementary Prognostic Value of Pelvic Magnetic Resonance Imaging and Whole-Body Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Pretreatment Assessment of Patients With Cervical Cancer (2015) (19)
PET imaging of HSV1-tk mutants with acquired specificity toward pyrimidine- and acycloguanosine-based radiotracers (2009) (18)
Congenital malformations of uterus and vagina. (1994) (18)
Trends in oncologic hybrid imaging (2018) (18)
Follow-Up Study of the Correlation Between Postoperative Computed Tomographic Scan and Primary Surgeon Assessment in Patients With Advanced Ovarian, Tubal, or Peritoneal Carcinoma Reported to Have Undergone Primary Surgical Cytoreduction to Residual Disease of 1 cm or Smaller (2009) (18)
Undescended Testis: Value of MR Imaging (1989) (18)
MR imaging of pathologic abdominal fluid collections. (1986) (17)
Assessment of testicular metabolic integrity with P-31 MR spectroscopy. (1987) (17)
Molecular imaging of prostate cancer: translating molecular biology approaches into the clinical realm (2015) (17)
Magnetic resonance imaging of the pelvis: Prostate and urinary bladder (1986) (17)
Role of MR Imaging and FDG PET/CT in Selection and Follow-up of Patients Treated with Pelvic Exenteration for Gynecologic Malignancies. (2015) (17)
Contrast‐enhanced MR imaging of the female pelvis (1993) (17)
Globalization of P4 medicine: predictive, personalized, preemptive, and participatory--summary of the proceedings of the Eighth International Symposium of the International Society for Strategic Studies in Radiology, August 27-29, 2009. (2011) (17)
Incorporation of postoperative CT data into clinical models to predict 5-year overall and recurrence free survival after primary cytoreductive surgery for advanced ovarian cancer. (2015) (17)
Prenatal MR imaging of congenital diaphragmatic hernia. (2000) (17)
Role of MRI in the evaluation of ambiguous genitalia. (1994) (16)
Characterization of prostate cancer with MR spectroscopic imaging and diffusion-weighted imaging at 3 Tesla. (2019) (16)
The Diagnostic Performance of the Length of Tumor Capsular Contact on MRI for Detecting Prostate Cancer Extraprostatic Extension: A Systematic Review and Meta-Analysis (2020) (16)
Plexiform neurofibroma involving the genitourinary tract in children: case reports and review of the literature. (1997) (16)
Carcinoma of the female reproductive organs. Value of cross‐sectional imaging (1991) (16)
Different Strategies for Reducing Intestinal Background Radioactivity Associated with Imaging HSV1-tk Expression Using Established Radionucleoside Probes (2010) (16)
CT of renal cell carcinoma: assessment of collecting system invasion. (2013) (16)
Preoperative assessment of retroperitoneal pathology by magnetic resonance imaging. Primary leiomyosarcoma of inferior vena cava. (1986) (16)
An exploratory study of endorectal magnetic resonance imaging and spectroscopy of the prostate as preoperative predictive biomarkers of biochemical relapse after radical prostatectomy. (2010) (16)
Are histopathological features of prostate cancer lesions associated with identification of extracapsular extension on magnetic resonance imaging? (2010) (16)
Assessment of in situ renal transplant viability by 31P-MRS: experimental study in canines. (1993) (16)
Shared Patient Analysis: A Method to Assess the Clinical Benefits of Patient Referrals (2001) (15)
Disease in the femoral triangle: sonographic appearance. (1982) (15)
MR imaging of diffusely infiltrating gastric carcinoma. (1987) (15)
Spermatic cord torsion: diagnostic limitations. (1985) (15)
Primary seminal vesicle adenocarcinoma. (2011) (15)
Magnetic resonance imaging in genital anomalies. (1987) (15)
Magnetic resonance imaging of vascular lesions of the scrotum and penis. (1995) (15)
New horizons in genitourinary oncologic imaging. (2006) (14)
Abdominal wall endometriosis: differentiation from other masses using CT features (2017) (14)
Urologic cancer. Methods of early detection and future developments (1987) (14)
The performance of PI-RADSv2 and quantitative apparent diffusion coefficient for predicting confirmatory prostate biopsy findings in patients considered for active surveillance of prostate cancer (2017) (14)
Ovarian Malignancies (2003) (14)
Androgen sensitivity of rat prostate carcinoma studied by 31P NMR spectroscopy, 1H MR imaging, and 23Na MR imaging (1989) (14)
Investigating women with suspected ovarian cancer. (2008) (14)
Pelvic lipomatosis: Diagnosis and characterization by magnetic resonance imaging (1988) (14)
The diagnostic value of renal cortex-to-medulla contrast on magnetic resonance images. (1986) (14)
Imaging appearance of granulomatous disease after intravesical Bacille Calmette-Guerin (BCG) treatment of bladder carcinoma. (2009) (14)
Current trends in MR imaging of the female pelvis. (1993) (13)
Renal cell carcinoma: A nomogram for the CT imaging-inclusive prediction of indolent, non-clear cell renal cortical tumours. (2016) (13)
Thoracic metastasis in advanced ovarian cancer: comparison between computed tomography and video-assisted thoracic surgery (2011) (13)
Assessment of male infertility: correlation between results of semen analysis and phosphorus-31 magnetic resonance spectroscopy. (1989) (13)
Phosphorus-31 MRS of the Kidney (1989) (13)
Renal transplant rejection: sonographic evaluation in children. (1984) (13)
Phosphorus-31 MRS of Human Testicular Function and Viability (1989) (13)
Integrated diagnostics: proceedings from the 9th biennial symposium of the International Society for Strategic Studies in Radiology (2012) (13)
Endometrial cancer of the uterus. American College of Radiology. ACR Appropriateness Criteria. (2000) (13)
Bile duct disease: Prospective comparison of ERCP, CT, and fat suppression MRI (1992) (13)
Magnetic resonance spectroscopic studies of the prostate. (2000) (13)
Prostate-specific membrane antigen positron emission tomography (PSMA-PET) for local staging of prostate cancer: a systematic review and meta-analysis (2020) (13)
Female urethral carcinoma: MRI staging. (1985) (13)
MR appearance of the liver after partial hepatectomy. (1989) (13)
Prognostic Value of Pretreatment MRI in Patients With Prostate Cancer Treated With Radiation Therapy: A Systematic Review and Meta-Analysis. (2019) (13)
Noncontrast and contrast enhanced MR imaging in the evaluation of partial ureteral obstruction: an experimental study in the micropig. (1989) (13)
Intradiverticular bladder cancer: CT imaging features and their association with clinical outcomes. (2015) (13)
Prostate volume measured preoperatively predicts for organ-confined disease in men with clinically localized prostate cancer. (2007) (12)
Role of imaging in the evaluation of pelvic cancer. (1991) (12)
Noninvasive imaging for staging of prostate cancer: magnetic resonance imaging, computed tomography, and ultrasound. (1988) (12)
Rapid, contrast-enhanced, diuretic magnetic resonance imaging of unilateral partial ureteral obstruction. An experimental study in micropigs. (1989) (12)
Role of imaging in cancer of the cervix. American College of Radiology. ACR Appropriateness Criteria. (2000) (11)
Clinical Application of Computational Methods in Precision Oncology: A Review. (2020) (11)
Imaging low-risk prostate cancer (2008) (11)
Bladder cancer imaging: an update (2011) (11)
Oncologic Imaging: Essentials of Reporting Common Cancers (2006) (11)
Prostate MRSI predicts outcome in radical prostatectomy patients. (2016) (11)
Acute effects of pelvic irradiation on the adult uterus revealed by dynamic contrast-enhanced MRI. (2013) (11)
Detection and Staging of Renal Neoplasms: A Reassessment of MR Imaging (1989) (10)
Widespread use of MRI in gynecology: a myth or reality? (1997) (10)
Prostate magnetic resonance imaging findings in patients treated for testosterone deficiency while on active surveillance for low-risk prostate cancer. (2016) (10)
Significance of Peritumoral Vascularity on CT in Evaluation of Renal Cortical Tumor (2007) (10)
Role of MRI in the diagnosis and management of prostate cancer. (2015) (10)
2-[F]Fluoro-2-Deoxyglucose Positron Emission Tomography for the Detection of Disease in Patients with Prostate-Specific Antigen Relapse after Radical Prostatectomy (2005) (10)
Improving Cancer Diagnosis and Care: Patient Access to High‐Quality Oncologic Pathology (2019) (10)
Patterns of Metastatic Disease in Patients with Cancer Derived from Natural Language Processing of Structured CT Radiology Reports over a 10-year Period. (2021) (10)
Radiation Exposure From Medical Imaging (2010) (10)
Prosthetic testicle: appearance at MR imaging. (1989) (10)
Magnetic resonance imaging: its application to male infertility. (1986) (10)
Ovarian cancer screening. American College of Radiology. ACR Appropriateness Criteria. (2000) (10)
Imaging Features of Uncommon Gynecologic Cancers. (2015) (10)
First trimester bleeding. American College of Radiology. ACR Appropriateness Criteria. (2000) (10)
Magnetic resonance imaging of the adrenal glands. (1984) (9)
Adult polycystic kidney disease: presymptomatic diagnosis for genetic counselling. (1983) (9)
Diagnostic Performance of Computed Tomography for Preoperative Staging of Patients with Non-endometrioid Carcinomas of the Uterine Corpus (2016) (9)
Magnetic resonance tumor volumetry in cervical cancer. (1996) (9)
MRI of a retained sponge in a dog. (1985) (9)
Can MRI of the pelvis be cost effective? (1997) (9)
Role of CT in the assessment of muscular venous branch invasion in patients with renal cell carcinoma. (2013) (9)
Ureteric bud remnant in two patients with renal agenesis: diagnosis by MRI. (1997) (9)
Imaging prostate carcinoma. (1988) (9)
Comparison of PI-RADS Versions 2.0 and 2.1 for MRI-based Calculation of the Prostate Volume. (2020) (9)
Temporal changes in MRI appearance of the prostate after focal ablation (2018) (9)
RETRACTED ARTICLE: New horizons in genitourinary oncologic imaging (2006) (9)
Comparison of diagnostic studies in the pretreatment evaluation of stage Ib carcinoma of the cervix. (1996) (9)
Association between penile dynamic contrast-enhanced MRI-derived quantitative parameters and self-reported sexual function in patients with newly diagnosed prostate cancer. (2014) (8)
Magnetic resonance imaging in the evaluation of urologic malignancies. (1985) (8)
Model selection for high b-value diffusion-weighted MRI of the prostate. (2018) (8)
Postoperative and postradiation changes in the pelvis. (1990) (8)
What do we expect from imaging? (2002) (8)
Clinical nuclear magnetic resonance imaging of the body. (1983) (8)
The expanding landscape of diffusion-weighted MRI in prostate cancer (2016) (8)
Quantification of Metastatic Prostate Cancer Whole-Body Tumor Burden with 18F-FDG PET Parameters and Associations with Overall Survival After First-Line Abiraterone or Enzalutamide: A Single-Center Retrospective Cohort Study (2021) (8)
The future of research in genitourinary radiology: through the looking glass--a view from the Society of Uroradiology. (1998) (8)
Edema and the lack of blood perfusion produce opposite effects on the magnetic resonance characteristics of acutely ischemic rat kidneys. (1987) (8)
The impact of scaling up access to treatment and imaging modalities on global disparities in breast cancer survival: a simulation-based analysis. (2021) (8)
Extracapsular extension on MRI indicates a more aggressive cell cycle progression genotype of prostate cancer (2019) (8)
Cost-effectiveness of new technologies for staging endometrial cancer (2000) (7)
Improving Cancer Diagnosis and Care: Patient Access to Oncologic Imaging Expertise. (2019) (7)
The Influence of Background Signal Intensity Changes on Cancer Detection in Prostate MRI. (2019) (7)
Magnetic resonance imaging evaluation of the irradiated female pelvis. (1994) (7)
Assessment of a retroperitoneal mass by magnetic resonance imaging in a 65-year-old woman. (1986) (6)
Magnetic resonance imaging of splenic iron overload. (1990) (6)
Medical applications of nuclear magnetic resonance imaging (1987) (6)
Advances in women's imaging. (1998) (6)
Given the improvement in pelvic coils for MR, is an endorectal coil necessary to evaluate prostate carcinoma? (1995) (6)
Magnetic resonance imaging diagnosis of hepatic metastases in the presence of negative CT studies. (1985) (6)
Diffuse retroperitoneal amyloidosis due to renal cell carcinoma. (1999) (6)
Sonography of renal transplant patients. (1982) (6)
Role of Molecular Imaging in the Era of Personalized Medicine: A Review (2014) (6)
Imaging in Gynaecology (2008) (6)
P-31 MR spectroscopy in assessing testicular torsion: rat model. (1989) (5)
Interactive, Up-to-date Meta-Analysis of MRI in the Management of Men with Suspected Prostate Cancer (2020) (5)
International Multi-Site Initiative to Develop an MRI-Inclusive Nomogram for Side-Specific Prediction of Extraprostatic Extension of Prostate Cancer (2021) (5)
Sonographic features of ATN and of acute rejection in renal allografts. (1980) (5)
22 A comparison of the prostate volume defined by magnetic resonance imaging and computerized tomographic (CT) scans during treatment planning for prostate cancer (1995) (5)
Determination of prostate volume with transrectal ultrasound for cancer screening. Part I. Comparison with prostate specific antigen assays. (1992) (5)
Reproducibility and clinical correlations of post-treatment changes on CT of prostate cancer bone metastases treated with chemotherapy. (2012) (5)
Prevalence and Correlates of Worry About the Health Harms of Medical Imaging Radiation in the General Population (2016) (5)
Ovarian Cancer: The Role of Functional Imaging as an End Point in Clinical Trials (2010) (5)
Role of imaging in second and third trimester bleeding. American College of Radiology. ACR Appropriateness Criteria. (2000) (5)
Closing the gender gap in academic radiology: reasons for hope? (2019) (5)
Mazaheri Y, Vargas HA, Akin O, Goldman DA, Hricak H. Reducing the influence of b‐value selection on diffusion‐weighted imaging of the prostate: evaluation of a revised monoexponential model within a clinical setting. J Magn Reson Imaging 2012;35:660–668 (2012) (5)
Women, careers, and academic radiology. (2000) (5)
Complete and partial ureteral obstruction: evaluation of renal effects with P-31 MR spectroscopy and Tc-DMSA scintigraphy. (1988) (5)
Oncologic Outcomes after Localized Prostate Cancer Treatment: Associations with Pre-treatment Prostate MRI Findings. (2020) (5)
Imaging of the genitourinary system. (1995) (5)
Enhancement of Ovarian Malignancy on Clinical Contrast Enhanced MRI Studies (2013) (5)
The radiology corner: duodenocolonic fistula with gallstone ileus. (1978) (5)
Liver lesion detection: Comparison between excitation-spoiling fat suppression and regular spin-echo at 1.5T (1993) (5)
Masters of radiology panel discussion: responding to health care reform and other market pressures. (2010) (4)
Local Extent of Prostate Cancer at MRI versus Prostatectomy Histopathology: Associations with Long-term Oncologic Outcomes. (2021) (4)
Residual prostate tissue after radical prostatectomy: acceptable surgical complication or treatment failure? (2010) (4)
Carcinoma of the Cervix and Endometrium (2002) (4)
Increasing Access to Imaging for Addressing the Global Cancer Epidemic. (2021) (4)
An 18-year-old woman born with cloacal exstrophy. (1986) (4)
MR imaging in gynecologic oncology (2004) (4)
Nuclear magnetic resonance and computed tomographic angiography in the detection of hepatic metastases. (1983) (4)
Role of imaging in abnormal vaginal bleeding. American College of Radiology. ACR Appropriateness Criteria. (2000) (4)
Addressing the challenge of managing radiation use in medical imaging: paradigm shifts and strategic priorities. (2014) (4)
Editorial on "The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix". (1994) (4)
The use of MRI in the diagnosis and management of a bulky cervical carcinoma. (2003) (4)
First open trial of the American College of Radiology Imaging Network: proper imaging approach for invasive cervical cancer. (2002) (4)
Renal cell carcinoma: Associations between tumor imaging features and epidemiological risk factors (2020) (4)
Advancing radiology through informed leadership: summary of the proceedings of the Seventh Biannual Symposium of the International Society for Strategic Studies in Radiology (IS3R), 23–25 August 2007 (2009) (4)
Prognostic Utility of MRI Features in Intradiverticular Bladder Tumor. (2020) (4)
Sonographic evaluation of the rejecting ureter (1986) (4)
View from above. (2012) (3)
Complex Posttransplantation Abnormalities of Renal Allografts: Evaluation (1999) (3)
Preoperative CT-based nomogram for predicting overall survival in women with non-endometrioid carcinomas of the uterine corpus (2015) (3)
Premature cervical dilatation. American College of Radiology. ACR Appropriateness Criteria. (2000) (3)
Recommendations for the Initial Cancer Staging MRI Report (2019) (3)
Radiological Evaluation of the Urinary Bladder, Prostate and Urethra (2008) (3)
Staging and follow-up of ovarian cancer. American College of Radiology. ACR Appropriateness Criteria. (2000) (3)
A statement about authorship from individual members of the International Society for Strategic Studies in Radiology. (2013) (3)
Discrimination of Choline-Positive Invasive Breast Carcinomas Using Water-to-Fat Ratio: A Proton MRS Study (2006) (3)
Magnetic resonance imaging in the evaluation of the retroperitoneum (1986) (3)
[Magnetic resonance imaging of the female pelvis]. (1994) (3)
National Trends in Oncologic Diagnostic Imaging. (2020) (3)
Masters of radiology panel discussion: role of communication in today's radiologic practices. (2010) (3)
Suspected adnexal masses. American College of Radiology. ACR Appropriateness Criteria. (2000) (3)
STATE OF THE ART : Imaging Prostate Cancer : Multidisciplinary Perspective (2007) (3)
Prostate and Seminal Vesicles (2000) (3)
Nuclear magnetic resonance imaging of atherosclerosis (1984) (3)
Comparisons of Water-to-Fat Ratios in Malignant , Benign Breast Lesions , and Normal Breast Parenchyma : An In Vivo Proton MRS Study (2005) (2)
Herbert Y. Kressel, MD, Named Editor of Radiology1 (2007) (2)
Safe spaces for women in challenging environments. (2019) (2)
Evaluation of multiple gestations. American College of Radiology. ACR Appropriateness Criteria. (2000) (2)
Subspecialty care in radiology: oncologic imaging. (1998) (2)
Clinical Stage T1c Prostate Cancer: Evaluation with Endorectal MRImagingandMRSpectroscopic (2009) (2)
Corrigendum to 'Diagnostic Performance of Vesical Imaging Reporting and Data System for the Prediction of Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis' [European Urology Oncology 3 (2020) 306-315]. (2020) (2)
The urinary bladder and female urethra (1992) (2)
Corrigendum to 'Diagnostic Performance of Vesical Imaging Reporting and Data System for the Prediction of Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis' [European Urology Oncology 3 (2020) 306-315]. (2020) (2)
Role of Endorectal Prostate MRI in Patients with Initial Suspicion of Prostate Cancer (2013) (2)
When Vision Prevails: A History of the International Society for Strategic Studies in Radiology. (2015) (2)
Congratulations to the 2004 Editorial Fellow1 (2004) (2)
Post-treatment alterations in 18F-dihydrotestosterone (FDHT) and FDG PET/CT in metastatic castration-resistant prostate cancer (mCRPC) treated with cabozantinib. (2013) (2)
A multicenter assessment of the ability of preoperative computed tomography scan and serum CA-125 to predict gross residual disease at primary debulking surgery for advanced ovarian, fallopian tube and peritoneal cancer (2015) (2)
Women's health care centers and the women's imaging subspecialty: emerging frontiers in radiology. (1999) (2)
Nuclear Magnetic Resonance (NMR) Imaging in Urologic Oncology (1984) (2)
Prostate Cancer: Index (2008) (2)
POST-TRANSPLANT RENAL FAILURE: DIFFERENTIAL DIAGNOSIS BY ULTRASOUND-EXPERIMENTAL AND CLINICAL OBSERVATIONS. (1980) (2)
Radiation Therapy Oncology Group. Research Plan 2002-2006. Gynecology Cancer Working Group. (2001) (2)
Women in focus: advice from the front lines on how to enable well-being and build resilience (2020) (2)
Oncologic Errors in Diagnostic Radiology: A 10-Year Analysis Based on Medical Malpractice Claims. (2021) (2)
The Society for the Advancement of Women's Imaging. Radiology: a partner in clinical care. (1998) (2)
The impact of systemic chemotherapy on testicular FDG activity in young men with Hodgkin’s lymphoma (2013) (2)
Corrigendum to “Molecular imaging for personalized cancer care” [Mol. Oncol. 6(2) (2012) 182–195] (2016) (2)
Role of Endorectal Prostate MRI in Patients with Initial Suspicion of Prostate Cancer (2013) (2)
Gynecology Cancer Working Group (2001) (2)
Jejunal diverticulitis with perforation. (1981) (2)
Prostatic Adenocarcinoma (2018) (2)
MRI and Choline-PET of the Prostate (2007) (2)
Magnetic resonance imaging-targeted prostate biopsies: now is the time to START. (2013) (2)
Volume and landmark analysis: comparison of MRI measurements obtained with an endorectal coil and with a phased-array coil. (2015) (2)
Masters of radiology panel discussion: Models for health care performance in radiology--how do we measure our productivity and ourselves? (2011) (2)
Chapter 1 – Imaging Strategies for Oncologic Diagnosis and Multidisciplinary Treatment (2002) (2)
Gynecologic tumor imaging. (1989) (2)
Women's imaging: an oncologic focus (2002) (1)
Multimodality imaging using proton magnetic resonance spectroscopic imaging and 18F-fluorodeoxyglucose-positron emission tomography in local prostate cancer (2017) (1)
MRI—Advance in patient care (2000) (1)
Effect of intravascular contrast agent on diffusion and perfusion fraction coefficients in the peripheral zone and prostate cancer. (2018) (1)
Many facets of prostate carcinoma. (1988) (1)
The role of MRI in prostate cancer: current and future directions (2022) (1)
Rak prostate - najvarijabilniji zloćudni tumor (2011) (1)
Localization of Prostate Cancer After Hormone Ablation by MRI and 3 D 1 H MRSI : Case-Control Study with Pathologic Correlation (1999) (1)
Management of the Fetus With Congenital Hydronephrosis (1983) (1)
Comprar Prostate Cancer | Hedvig Hricak | 9780521887045 | Cambridge University Press (2008) (1)
3.12 – MR Imaging of the Prostate (2014) (1)
Imaging and management of atypical testicular masses : Testis cancer (1998) (1)
Corrigendum to "Molecular imaging for personalized cancer care" [Mol. Oncol. 6(2) (2012) 182-195]. (2016) (1)
An exploratory study of endorectal MRI and spectroscopy of the prostate as pre-operative predictive biomarkers of biochemical relapse after radical prostatectomy (2011) (1)
Nuclear magnetic resonance imaging of the cardiovascular system: Normal and pathologic findings (1984) (1)
Imaging in infertility (1999) (1)
Tumors of the Scrotum (2002) (1)
Deep learning achieves radiologist-level performance of tumor segmentation in breast MRI (2020) (1)
Current role of magnetic resonance imaging in urology (1995) (1)
Comprar Diagnostic Imaging: Gynecology | Hedvig Hricak | 9781416033387 | Elsevier Internacional (2008) (1)
Radiation Brain Drain? The Impact of Demographic Change on U.S. Radiation Protection (2017) (1)
Reporter Gene ( GLV-1 h 99 ) Using a Human Norepinephrine Transporter Imaging a Genetically Engineered Oncolytic Vaccinia Virus (2009) (1)
Image interpretation session. Sunday, December 1, 2002. (2002) (1)
RECOVERY OF URINARY CONTINENCE AFTER RADICAL PROSTATECTOMY: ASSOCIATION WITH URETHRAL LENGTH MEASURED BY PRE- AND POSTOPERATIVE ENDORECTAL MAGNETIC IMAGING (2008) (1)
Cervical carcinoma: role of imaging (1997) (1)
MRI-Detectability of Clinically Significant Prostate Cancer Relates to Oncologic Outcomes After Prostatectomy. (2022) (1)
From the RSNA Refresher Courses (1999) (1)
The role of intestinal microflora in nucleoside analog HSV1-TK microPET imaging, different strategies in reducing intestinal background radioactivity (2009) (1)
Scrotal sonography. (1985) (1)
Changes in proton relaxation times of the rat spleen during adjuvant-induced immunologic reaction. (1986) (1)
Biochemical Response of Prostate Cancer Cells to Hormone Deprivation Detected by Magnetic Resonance Spectroscopy (1987) (1)
Automatic Forecasting of Radiology Examination Volume Trends for Optimal Resource Planning and Allocation (2021) (1)
Characterization of Renal Masses with Diffusion-Weighted MR Imaging-- A Preliminary Experience (2007) (1)
Urachal carcinoma (1985) (1)
Complete and Partial Ureteral Obstruction: Evaluation of Renal Effects With P-31 MR Spectroscopy and Tc-DMSA Scintigraphy (1989) (1)
Emergency room imaging in patients with genitourinary cancers: analysis of the spectrum of CT findings and their relation to patient outcomes (2020) (1)
Systems Biology and Nanotechnology (2008) (1)
Prostate Cancer: Plate section (2008) (1)
Advancing molecular imaging: a chairman’s perspective on how radiology can meet the challenge (2011) (1)
A pattern recognition model for automatic classification of 1 H MRSI voxels in the prostate (2008) (1)
MR Imaging of the Seminal Vesicles Pictorial Essay (2005) (1)
Radiology 2040. (2023) (1)
Cancer of the prostate (2002) (1)
Pre-clinical evaluation of 124I-FIAU and 18F-FIAU for the assessment of the HSV1-tk reporter gene expression with PET (2009) (1)
Improved Robustness with a Stretched Exponential Model for Intravoxel Incoherent Motion ( IVIM ) DW Signal (2009) (0)
ROLE OF ULTRASOUND IN ACUTE PORT-TRANSPLANT RENAL FAILURE EXPERIMENTAL AND CLINICAL OBSERVATIONS. (1979) (0)
Faculty Opinions recommendation of Prostate cancer - the role of magnetic resonance imaging. (2012) (0)
MRI of the prostate: Clinical relevance and emerging applications (2011) (0)
Congratulations to the 2005 Editorial Fellows1 (2005) (0)
Oncologic imaging in 2002 and beyond (2002) (0)
Nuclear magnetic resonance imaging of the kidney (1984) (0)
Magnetic resonance imaging of the kidney (1992) (0)
Impact of 18F-Fluorodeoxyglucose positron emission tomography on management of cancer of unknown primary: systematic review and meta-analysis. (2021) (0)
CP4-7 Up-to-date radiologic diagnosis of urological cancers (2004) (0)
Registration of Magnetic Resonance Images of the Prostate Obtained with an Endorectal Coil to Histological Sections (2008) (0)
Pocket radiologist : Top 100 diagnoses (2001) (0)
Lancet Oncology Commission on Medical Imaging and NuclearMedicine (2021) (0)
MO-C-500-00: President's Symposium: Introduction S Donaldson*, RSNA President. (2013) (0)
Non mono-exponential Analysis of DW-MRI data for the Detection of Prostate Cancer (2010) (0)
TU‐AB‐BRA‐01: Classification of Prostate Cancer Gleason Scores Through Machine Learning From Multiparametric MRI (2015) (0)
Image Interpretation Session: 20021 (2003) (0)
Imaging in Radiation Therapy (2006) (0)
Current status of MRImaging of the female pelvis (1989) (0)
Imaging of Cervical and Endometrial Cancer (2011) (0)
Radiology in 2002 and Beyond (2002) (0)
Magnetic resonance imaging of hemorrhagic lesions: evolution of the intrinsic relaxation parameters from time of onset of symptoms. (1986) (0)
PD4-11 INCREASING ELIGIBILITY FOR PROSTATE CANCER ACTIVE SURVEILLANCE: THE VALUE OF MULTIPARAMETRIC MRI FOR THE PREDICTION OF PATHOLOGICAL DOWNGRADING AFTER RADICAL PROSTATECTOMY IN PATIENTS WITH BIOPSY-PROVEN GLEASON 3 + 4 PROSTATE CANCER (2014) (0)
Recent Advances in Cancer Imaging as Applied to Radiotherapy (2003) (0)
Fat-containing adnexal masses on MRI: solid tissue volume and fat distribution as a guide for O-RADS Score assignment (2022) (0)
Pretreatment of Prostate Cancer: Role of MR Imaging and 1 HM R Spectroscopy 1 (2004) (0)
Letters to the Editor All Structured Reporting Systems Are Not Created Equal From (0)
32 The Case for MRI (0)
Female Urethral Carcinoma: MRI Staging (1985) (0)
Imaging in Newly Diagnosed Prostate Cancer (2011) (0)
Pocket Atlas of MRI of the Pelvis (1993) (0)
Genitourinary radiology. (1995) (0)
Foreword for gynecologic imaging across the life span. (2012) (0)
2010 RSNA Outstanding Researcher (2010) (0)
Clinical nuclear magnetic resonance imaging of the body (1984) (0)
157 Usefulness of MRI in the Evaluation of Abscesses (1985) (0)
Work in progress; Nuclear magnetic resonance imaging of the gallbladder (1984) (0)
Chapter 5 – Imaging of Ovarian Cancer (2010) (0)
THE OVARY (1993) (0)
Prostate Cancer: Current clinical issues in prostate cancer that can be addressed by imaging (2008) (0)
43 Pelvic interstitial brachytherapy — improving the therapeutic ratio with magnetic resonance imaging and optimization (1996) (0)
Brachythérapie prostatique: Imagerie par IRM endorectale des modifications locales induites par le traitement (2001) (0)
Imaging in Oncology (2017) (0)
Building the Diagnostic Cockpit of the Future : An Opportunity to Improve Diagnostic Accuracy and Precision (2018) (0)
URETERAL PERISTALSIS IN THE REJECTING ALLOGRAFT (1980) (0)
Can Intravenous Urography be Replaced by Sonography (1990) (0)
13. Jahreskongress SGNM, 13ème Congrès annuel SSMN (2013) (0)
Imaging in urology – looking forward (2008) (0)
What is the probability of a positive bone scan (+BS) in patients with a rising PSA after radical prostatectomy (RP): A new nomogram. (2004) (0)
Magnetic Resonance (1962) (0)
Growth disturbances: risk of intrauterine growth retardation. American College of Radiology. ACR Appropriateness Criteria. (2000) (0)
The use of cross-sectional imaging to determine nonresectability of primary ovarian cancer (1998) (0)
Role of preoperative MRI in improving the selection of patients with early-stage cervical cancer for fertility-sparing surgery (2012) (0)
Magnetic resonance imaging evaluation of radiation-induced changes in experimentally implanted renal cell carcinoma. (1987) (0)
Congratulations to the 2009 RSNA Outstanding Educator: Elliot K. Fishman, MD. (2010) (0)
A study of endorectal MRI and MRSI of the prostate as predictive biomarkers of biochemical relapse after radical prostatectomy (2010) (0)
Special issue: Women's MR (2001) (0)
Radiology of Renal Masses (1985) (0)
Special Communication: Congratulations to the 2007 Editorial Fellows (2004) (0)
Faculty Opinions recommendation of Quantum dots: emerging applications in urologic oncology. (2008) (0)
A new HSV1-tk acycloguanosine specific mutant for PET imaging for potential use in patients treated with pyrimidine-based cytotoxic drugs (2008) (0)
Faculty Opinions recommendation of Impact of tumor size on the predictive ability of the pT3a primary tumor classification for renal cell carcinoma. (2007) (0)
Chapter 71 – Imaging of Gynecologic Malignancies (2004) (0)
853: Bone Scan in Assessing Biochemical Failure After Radical Prostatectomy – Efficacy and Risk Factors for a Positive Scan (2004) (0)
MRI Prostate Volumetry as a Surrogate for Transrectal Ultrasound Volumetry in Estimating Iodine – 125 Seeds in Brachytherapy: conventional prolate ellipsoid volume algorithm versus a modified bullet-shape volume algorithm (2011) (0)
Imaging of the scrotum: Text and atlas (2005) (0)
Oncologic imaging using MRI and MR spectroscopic imaging (2000) (0)
Imaging for Metastatic Prostate Cancer (2011) (0)
5095 Comparison of Different Fitting Algorithms for Analysis of High b-value Prostate Diffusion Imaging (2013) (0)
Female pelvis: overcoming hurdles to cancer staging. (1993) (0)
Magnetic resonance. (1991) (0)
Nuclear magnetic resonance imaging of the kidney: Renal masses (1984) (0)
Correlation between pretreatment MRI/MRSI data and tissue molecular marker levels for characterization of prostate cancer and prediction of disease recurrence (2009) (0)
Comment on: Focal Therapy for Localized Prostate Cancer : A Critical Appraisal of Rationale and Modalities. Authors' reply (2008) (0)
Congratulations to the 2006 Editorial Fellows (2006) (0)
Male Pelvis Studies Using MRI (2007) (0)
Chapter 40 – Late Effects (2002) (0)
KAPITEL 26 – Multiples Myelom (2009) (0)
Emergency room imaging in pediatric patients with cancer: analysis of the spectrum and frequency of imaging modalities and findings in a tertiary cancer center and their relationship with survival (2021) (0)
Nuclear magnetic resonance imaging of the adrenal gland: A preliminary report (1984) (0)
81 Magnetic resonance differentiation of solid and cystic masses (1985) (0)
Applications of magnetic resonance imaging in clinical urology. (1985) (0)
Comprar Update on Radiologic Evaluation of Common Malignancies, An Issue of Radiologic Clinics,45-1 | Hedvig Hricak | 9781416047889 | Saunders (2007) (0)
Faculty of 1000 evaluation for Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy. (2012) (0)
Prostate cancer - most variable malignant tumour (2010) (0)
Prostate Cancer: Preface (2008) (0)
Response assessment parameters in esophageal cancer - conventional and novel techniques. (2004) (0)
PocketRadiologist - Gynecologic Top 100 Diagnoses, CD-ROM PDA Software - Pocket PC Version (2004) (0)
Genitourinary radiology. (1996) (0)
New pyrimidine-specific human-derived reporter genes suitable for clinical PET imaging (2010) (0)
Hodgkin's Disease, Lymphomas, and the Lymphoproliferative Disorders (2002) (0)
1149: Impact of a Multidisciplinary Continuous Quality Improvement Program on the Positive Surgical Margin Rate after Laparoscopic Radical Prostatectomy (2006) (0)
The prognostic significance of supradiaphragmatic lymphadenopathy identified on preoperative computed tomography scan in patients undergoing primary cytoreduction for advanced stage epithelial ovarian cancer. (2009) (0)
Magnetic Resonance Imaging with Respiratory (1984) (0)
Global challenges in oncologic imaging (2014) (0)
Development of HSV1-tk mutants with altered activity towards acycloguanosine analogs (2008) (0)
THE EFFECT OF HYPERALIMENTATION ON THE SONOGRAPHIC FEATURES OF ACUTE REJECTION-EXPERIMENTAL STUDY (1980) (0)
Oncologic Imaging, Second Edition (2002) (0)
SU‐E‐J‐255: Automatic Segmentation Refined, Multiple Slice‐Wise Voting Based Classification of Tumors From MRI (2015) (0)
Prostate cancer in 2017: Advances in imaging (2018) (0)
“RENAL SINUS DURING ALLOGRAFT REJECTION: SONOGRAPHIC HISTOPATHOLOGIC CORRELATION” (1981) (0)
Radiology: A Partner in Clinical Care1 (1998) (0)
[Nuclear magnetic resonance in the study of pathology of the whole body (III)]. (1989) (0)
684: Use of MRI in the Analysis of Corporal Fibrosis in the RAT (2007) (0)
Sonographic features of gastrointestinal neoplasms. (1982) (0)
Faculty Opinions recommendation of White fat, factitious hyperglycemia, and the role of FDG PET to enhance understanding of adipocyte metabolism. (2012) (0)
Diagnosing , Staging and Stratifying Patients with Malignant Uterine Disease (2006) (0)
Retrospective Analysis of a Guideline for Evaluating Nontraumatic Abdominal Pain in Older Patients Presenting to the Emergency Department (2003) (0)
Spectrally-Selective IR Diffusion-Weighted Imaging with SSFP of Bone Marrow at 3T (2008) (0)
Magnetic Resonance Imaging in Gynecologic Oncology: Role in Pre- and Postradiation Treatment (1992) (0)
New horizons in oncologic imaging (2007) (0)
News From the Academy. (2019) (0)
Oncologic Imaging: Today and Tomorrow (2011) (0)
CHANGES FOLLOWING ACUTE URETERAL OBSTRUCTION IN PIGS AS SEEN WITH Tc‐99m‐DMSA AND MAGNETIC RESONANCE SPECTROSCOPY.: D5 (1986) (0)
NMR IMAGING OF ATHEROSCLEROSIS AND VASCULAR FLOW ABNORMALITIES (1983) (0)
Programmatic Implementation of a Custom Subspecialized Oncologic Imaging Workflow Manager at a Tertiary Cancer Center. (2022) (0)
The value of pre- and post-processing of liver images in the detection of liver masses. (1983) (0)
Congratulations to the 2005 Editorial Fellows (2005) (0)
renal cell carcinoma: Role of MR Imaging in the Assessment of Muscular Venous Branch Invasion 1 (2013) (0)
Molecular Imaging of Prostate Cancer 1 (2015) (0)
Imaging in gynecology (1997) (0)
GRANULOMATOUS PROSTATITIS MIMICKING PROSTATE CANCER ON MAGNETIC RESONANCE IMAGING: REPORT OF TWO CASES (2017) (0)
Multistakeholder Needs Assessment to Inform the Development of an mHealth-Based Ultrasound-Guided Breast Biopsy Training Program in Nigeria (2020) (0)
THE ROLE OF RETROGRADE PYELOGRAPHY IN ASSESSING RENAL TRANSPLANT RECIPIENTS (1981) (0)
STAR ABSTRACT Imaging prostate cancer (2017) (0)
Personalized Medicine and Imaging Prostate MRI : Evaluating Tumor Volume and Apparent Diffusion Coef fi cient as Surrogate Biomarkers for Predicting Tumor Gleason Score (2014) (0)
Magnetic resonance imaging and pelvic abnormalities. (1987) (0)
Retraction Note to: New Horizons in Genitourinary Oncologic Imaging (2015) (0)
Prediction of prostate cancer outcomes by MR spectroscopic imaging: Preliminary results (1998) (0)
Herbert Y. Kressel, MD, named editor of radiology. (2007) (0)
1919: CT Urography for Surveillance Following Radical Cystectomy and Urinary Diversion (2004) (0)
Dr. Hricak replies (1983) (0)
CP2-8 Magnetic resonance spectroscopic imaging of the prostate cancer (2004) (0)
Regarding the Focal Treatment of Prostate Cancer: Inference of the Gleason Grade From MR Spectroscopic Imaging (2007) (0)
ECR 2011 Book of Abstracts - A - Postgraduate Educational Programme (2011) (0)
135. ATN AND RENAL ALLOGRAFT REJECTION - POTENTIAL OF MRI: EXPERIMENTAL STUDY (1984) (0)
Maximum likelihood analysis provides accurate ADC estimates from diffusion-weighted prostate images acquired with multichannel coils (2009) (0)
Congratulations to the 2007 Editorial Fellows (2007) (0)
Localizing sites of disease in patients with rising PSA up to 1 ng/mL following prostatectomy: how much information can conventional imaging provide? (2016) (0)
Response to editorial by Dr. Maruyama. (1993) (0)
NUCLEAR MAGNETIC RESONANCE IMAGING OF VASCULATURE OF ABDOMINAL VISCERA. NORMAL AND PATHOLOGIC FINDINGS (1983) (0)
122. RELATIVE INTENSITY OP ABDOMINAL ORGANS IN MRI (1984) (0)
Correction of data reporting errors. (2013) (0)
Imaging in Radiation Therapy - Recent advances and their role in radiotherapy (2006) (0)
Accurate estimation of diffusion kurtosis (DK) imaging parameters of the prostate (2018) (0)
Contents, Vol. 53, 1994 (1994) (0)
Endorectal MR Imaging and Proton Spectroscopy for Preoperative Evaluation of Clinical T 1 c Prostate Cancer (2007) (0)
Hormone Ablation of Localized Prostate Cancer : Effects of Duration of Therapy on Prostate Metabolism Demonstrated by 3 D ‘ H MR Spectroscopy (1999) (0)
MR Imaging of Treated Prostate Cancer 1 (0)
586 Response assessment classification: effect of multiple measurement criteria and parameters (2004) (0)
Tissue segmentation improves prostate cancer detection with artificial neural networks analysis of 1 H MRSI (2009) (0)
3.22 – Clinical Applications of Magnetic Resonance Spectroscopic Imaging (2014) (0)
Metabolic signature of prostate cancer as detected with proton magnetic resonance spectroscopic imaging and 18 F-fluorodeoxyglucose-positron emission tomography (2012) (0)
Renal Cell Carcinoma: A nomogram for the CT imaging-inclusive prediction of indolent, non-clear cell renal cortical tumors (2016) (0)
Congratulations to the 2006 Editorial Fellows1 (2006) (0)
Prostate Carcinoma – Cross-Sectional Imaging Techniques (2009) (0)
Faculty Opinions recommendation of Case report: Perforated haemorrhagic cholecystitis: MR imaging features. (2006) (0)
Correlation between Imaging-based Intermediate Endpoints and Overall Survival in Men with Metastatic Castration-Resistant Prostate Cancer: Analysis of 28 Randomized Trials using the Prostate Cancer Clinical Trials Working Group (PCWG2) criteria in 16,511 patients (2021) (0)
A Conversation Between Hedvig Hricak and Johannes Czernin (2019) (0)
Subject Index Vol. 53, 1994 (1994) (0)

This paper list is powered by the following services:

Other Resources About Hedvig Hricak

What Schools Are Affiliated With Hedvig Hricak?

Hedvig Hricak is affiliated with the following schools:

Hedvig Hricak's Academic­Influence.com Rankings